Erythropoietin in anemia of the premature infant. Neonatal factors that are predictors of transfusion;Eritropoyetina en la anemia de la prematuridad. Factores neonatales predictores de transfusiones

Anales Espanoles de Pediatria

Volumn 49, Issue 1, 1998, Pages 49-54

  Sastre Huerta, E ^a   Alonso Alvarez, B ^a   Montero Alonso, R ^a   Alvarez Martin, T ^a   Barbadillo Izquierdo, F ^a   Carpintero Martin, I ^a   Gil Rivas, T ^a   Suarez Fernandez J ^a  

^a HOSPITAL UNIVERSITARIO DE BURGOS   (Spain)

Author keywords

Anemia in the premature infant; Erythropoietin

Indexed keywords

ALPHA TOCOPHEROL; FERRITIN; FERROUS SULFATE; HEMOGLOBIN; IRON; MULTIVITAMIN; RECOMBINANT ERYTHROPOIETIN;

ARTICLE; ARTIFICIAL VENTILATION; BLOOD TRANSFUSION; CLINICAL ARTICLE; CONTROLLED STUDY; DRUG EFFICACY; FEMALE; GESTATIONAL AGE; HEMATOCRIT; HUMAN; IRON DEFICIENCY ANEMIA; IRON THERAPY; LOW BIRTH WEIGHT; LUNG DYSPLASIA; MALE; NEONATAL RESPIRATORY DISTRESS SYNDROME; NEWBORN; NEWBORN ANEMIA; ORAL DRUG ADMINISTRATION; PREMATURITY; RISK FACTOR; SEPSIS; SUBCUTANEOUS DRUG ADMINISTRATION;

ANEMIA; CASE-CONTROL STUDIES; ERYTHROCYTE TRANSFUSION; ERYTHROPOIETIN, RECOMBINANT; HUMANS; INFANT, PREMATURE; PROGNOSIS; RISK FACTORS;

EID: 0002095083     PISSN: 03024342     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (26)

1. Halperin DS. Use of recombinant erythropoietin in treatment of the anemia of prematurity. Am J PedialrOncol 1991; 13:351-363.
2. Phibbs RH. Potential for treatment of anemia of prematurity with recombinant human erythropoietin. Curr Opln Pediatr 1995; 7:140-145.
3. Strauss RG. Erytrhopoietin and neonatal anemia. N Engl J Med 1994; 330:227-228.
4. Soubasi V, Kremenopoulos G, Diamanti E y cols. Follow-up of very low birth weight infants after erythropoietin treatment to prevent anemia of prematurity. J Pediatr 1995; 127:291-297.
5. Shannon KM, Mentzer WC, Abels RI y cols. Recombinant human erythropoietin in anemia of prematurity: results of a placebo controlled pilot study. J Pediatr 1991; 118:949-955.
6. Stockman JA, Oski FA. Physiological anemia of infancy and the anemia of prematurity. Clin Hematol 1978; 7:3-18.
7. Strauss RG. Erythropoietin in the pathogenesis and treatment of neonatal anemia. Transfusion 1995; 35:68-73.
8. Oski FA. Neonatal hematology. The erythrocite and his disorders. En: Hematology of infancy and childhood, 3rd edition. Philadelphia: WB Saunders, p. 40.
9. Williams JA, Grist WM. Erythropoietin not yet a standard treatment for anemia of prematurity. Pediatrics 1995; 95:9-10.
10. Meyer MP, Meyer JH, Commerford A y cols. Recombinant human erythropoietin in the treatment of anemia of prematurity: results of a double-blind placebo-controlled study. Pediatrics 1994; 93:918-923.
11. Maler RF, Obladen M, Scigalla P y cols. The effect of epoetin beta (recombinant human erythropoietin) on the need for transfusion in very-low-birth-weight infants. European Multicentre Erythropoietin Study Group. N Engt J Med 1994; 330:1173-1178.
12. Shannon KM, Keith JF, Mentzer RA y cols. Recombinant human eryth-ropoietin stimulates erythropoiesis and reduces erythrocite transfusions in very low birth weight preterm infants. Pediatrics 1995; 95:1-8.
13. Emmerson AJ, Coles HJ, Stern CM, Pearson TC. Double blind trial of recombinant human erythropoietin in preterm infants. Arch Dis Child 1993; 68:291-296.
14. Bechensteen AG, Haga P, Halvorsen S y cols. Erythropoietin, protein and iron supplementation and the prevention of anemia of prematurity. Arch Dis Child 1993; 69:19-23.
15. Shannon KM, Mentzer WC, Abels RI y cols. Enhacement of erythropoiesis by recombinant human erythropoietin in low birth weight infants: a pilot study. J Pediatr 1992; 120:586-592.
16. Halperin DS, Felix M, Wacker P y cols. Recombinant human erythropoietin in the treatment of infants with anemia of prematurity. Eur J Pediatr 1992; 151:661-667.
17. Beck D, Masserey E, Meyer M, Calame A. Weekly intravenous administration of recombinant human erythropoietin in infants with anemia of prematurity. Eur J Pediatr 1991; 150:767-772.
18. Chen J Y, Wu TS, Chanlai SP. Recombinant human erythropoietin in the treatment of anemia of prematurity. Am J Perinatal 1995; 12:314-318.
19. Carnielli V, Montini G, da Riol R y cols. Effect of high doses of human recombinant erythropoietin on the need for blood transfusions in preterm infants. J Pediatr 1992; 121:98-102.
20. Shannon K. Recombinant human erythropoietin in neonatal anemia. Clin Perinatal 1995; 3:627-640.
21. Soubasi V, Kremenopoulos G, Diamandi E y cols. In which neonates does early recombinant human erythropoietin treatment prevent anemia of prematurity? Results of a randomized, controlled study. Pediatr Res 1993; 35:675-679.
22. Ohls RK, Christensen RD. Recombinant erythropoietin compared with erythrocyte transfusion in the treatment of anemia of prematurity. J Pediatr 1991; 119:781-788.
23. Zuppa AA, Mazzotta M, Maragliano G y cols. Anemia of prematurity: risk factors influencing red cell transfusions. Minerva Pediatr 1995; 47:13-18.
24. Zachee P. Controversies in selection of epoetin dosages. Issues and answers. Drugs 1995; 49:536-547.
25. Brown MS, Berman ER, Luchey D. Prediction on need for transfusion during anemia of prematurity. J Pediatr 1990; 116:773-778.
26. Strauss RG. Erythropoietin and neonatal anemia. NEnglJMed 1994; 330:1227-1228.